These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 8918569)
1. The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone. Macanovic M; Sinicropi D; Shak S; Baughman S; Thiru S; Lachmann PJ Clin Exp Immunol; 1996 Nov; 106(2):243-52. PubMed ID: 8918569 [TBL] [Abstract][Full Text] [Related]
2. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887 [TBL] [Abstract][Full Text] [Related]
3. DNAse treatment does not improve the survival of lupus prone (NZB x NZW)F1 mice. Verthelyi D; Dybdal N; Elias KA; Klinman DM Lupus; 1998; 7(4):223-30. PubMed ID: 9643311 [TBL] [Abstract][Full Text] [Related]
4. Soluble human CD83 ameliorates lupus in NZB/W F1 mice. Starke C; Steinkasserer A; Voll RE; Zinser E Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695 [TBL] [Abstract][Full Text] [Related]
5. Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay. Macanovic M; Lachmann PJ Clin Exp Immunol; 1997 May; 108(2):220-6. PubMed ID: 9158089 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055 [TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus. McMurray RW; Elbourne KB; Lagoo A; Lal S J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431 [TBL] [Abstract][Full Text] [Related]
8. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene. Szalai AJ; Weaver CT; McCrory MA; van Ginkel FW; Reiman RM; Kearney JF; Marion TN; Volanakis JE Arthritis Rheum; 2003 Jun; 48(6):1602-11. PubMed ID: 12794828 [TBL] [Abstract][Full Text] [Related]
9. Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB x NZW) F1 mice. Chen SY; Chen YC; Wang JK; Hsu HP; Ho PS; Chen YC; Sytwu HK Clin Immunol; 2003 Aug; 108(2):103-10. PubMed ID: 12921756 [TBL] [Abstract][Full Text] [Related]
10. Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE). Suwannaroj S; Lagoo A; Keisler D; McMurray RW Lupus; 2001; 10(4):258-65. PubMed ID: 11341102 [TBL] [Abstract][Full Text] [Related]
11. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid. Suwannaroj S; Lagoo A; McMurray RW Lupus; 2001; 10(8):562-7. PubMed ID: 11530998 [TBL] [Abstract][Full Text] [Related]
12. Histopathology of lupus-like nephritis in Dnase1-deficient mice in comparison to NZB/W F1 mice. Jacob M; Napirei M; Ricken A; Dixkens C; Mannherz HG Lupus; 2002; 11(8):514-27. PubMed ID: 12220106 [TBL] [Abstract][Full Text] [Related]
13. Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28. Laurent L; Le Fur A; Bloas RL; Néel M; Mary C; Moreau A; Poirier N; Vanhove B; Fakhouri F Eur J Immunol; 2017 Aug; 47(8):1368-1376. PubMed ID: 28631301 [TBL] [Abstract][Full Text] [Related]
14. [Extracorporeal treatment of nucleoprotein disposal disorders using the systemic lupus erythematosus model: evaluation of efficacy and safety in a short-term simulated experiment]. Trofimenko AS; Gontar IP; Paramonova OV; Simakova ES; Zborovskaya IA Biomed Khim; 2015; 61(5):622-7. PubMed ID: 26539870 [TBL] [Abstract][Full Text] [Related]
15. The in vivo destruction of antigen--a tool for probing and modulating an autoimmune response. Lachmann PJ Clin Exp Immunol; 1996 Nov; 106(2):187-9. PubMed ID: 8918561 [No Abstract] [Full Text] [Related]
16. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus. Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631 [TBL] [Abstract][Full Text] [Related]
17. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. Schiffer L; Sinha J; Wang X; Huang W; von Gersdorff G; Schiffer M; Madaio MP; Davidson A J Immunol; 2003 Jul; 171(1):489-97. PubMed ID: 12817034 [TBL] [Abstract][Full Text] [Related]
19. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice. Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377 [TBL] [Abstract][Full Text] [Related]